FMP
Pharnext SA
ALPHA.PA
EURONEXT
Inactive Equity
Pharnext SA, a clinical-stage biopharmaceutical company, develops therapies for orphan and common neurodegenerative diseases in France. The company's products include SYNGILITY that has completed Phase III trial for the treatment of Charcot-Marie-Tooth disease type 1A; and PXT864, which has completed Phase II clinical trial to treat Alzheimer's disease, as well as Parkinson's disease and amyotrophic lateral sclerosis. It also develops PLEOTHERAPY, a big genetic data and artificial intelligence platform. Pharnext SA has an agreement with the University Hospital Institute Mediterranee Infection to evaluate repurposed drugs for potential use against the COVID-19 virus. The company was founded in 2007 and is headquartered in Issy-Les-Moulineaux, France.
0.13 EUR
-0.0197 (-15.15%)
About
ceo
Mr. Hugo Brugiere M.Sc.
sector
Healthcare
industry
Biotechnology
website
https://www.pharnext.com
exchange
EURONEXT
Description
Pharnext SA, a clinical-stage biopharmaceutical company, develops therapies for orphan and common neurodegenerative diseases in France. The company's products include SYNGILITY that has completed Phase III trial for the treatment of Charcot-Marie-Tooth disease type 1A; and PXT864, which has completed Phase II clinical trial to treat Alzheimer's disease, as well as Parkinson's disease and amyotrophic lateral sclerosis. It also develops PLEOTHERAPY, a big genetic data and artificial intelligence platform. Pharnext SA has an agreement with the University Hospital Institute Mediterranee Infection to evaluate repurposed drugs for potential use against the COVID-19 virus. The company was founded i...
CIK
N/A
ISIN
FR001400N1P4
CUSIP
F70930122
Address
Immeuble Vivaldi
Phone
33 1 41 09 22 30
Country
FR
Employee
23
IPO Date
Jul 18, 2016
Summary
CIK
-
Exchange
EURONEXT
Industry
Biotechnology
Sector
Healthcare
CUSIP
F70930122
ISIN
FR001400N1P4
Country
FR
Price
0.13
Beta
-315.38
Volume Avg.
20.09k
Market Cap
28.42k
Shares
-
52-Week
0.1201-8.04E7
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
0
P/B
-
Website
https://www.pharnext.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ALPHA.PA News
It looks like there's no news available.
